DXCM News and Press, DexCom Inc. From 03/26/23

2023-03-26 12:00:27 ET The market for continuous glucose monitoring systems, where companies such as Abbott Laboratories ( ABT ) and DexCom ( NASDAQ: DXCM ) dominate, is expected to reach $31.7B by 2031, Allied Market Research said in a recent industry report. Rising dia...

2023-03-25 05:41:00 ET The past 15 months haven't been easy for growth stock investors. The Nasdaq Composite index has fallen a disappointing 25% since the beginning of 2022, making this an unusually long bear market . You don't need an economics degree to see that every bear ma...

The removal of the age restriction and inclusion of type 2 diabetes will enable more people with diabetes to access Dexcom’s real-time CGM System – the standard of care in diabetes management Dexcom, Inc. (NASDAQ: DXCM), a global leader in real-time continuous glucose moni...

2023-03-20 11:10:25 ET Summary Abbott has had a crazy couple of years, with a formula recall and a COVID testing boom. Through this year, most of that should start to normalize, and the Libre 3 launch and growth in the diabetes market should remain a long-term tailwind for the com...

2023-03-15 18:32:35 ET Summary DexCom has built itself an impressive market position against large competitors in the diabetes space. Future growth should remain relatively easy as reimbursed populations continue to grow, and the overall diabetes market is expanding. Despite a...

2023-03-15 08:15:43 ET The Internet of Things (IoT) is seen as a major growth theme for investors over coming years because it has the potential to revolutionize the […] For further details see: Why IoT Stocks Could Retake the Spotlight (CSCO, PBTS, ALRM, DXCM, PI, INTC)

DexCom, Inc. (NASDAQ: DXCM), today issued the following statement in response to speculation following the developments at Silicon Valley Bank, including a recent CNBC article: “Dexcom does not have material exposure to the developments at Silicon Valley Bank, including with respect ...

2023-03-09 08:00:00 ET You don't need to have a lot of cash on hand to start investing in the stock market. Even if you've only got a few hundred dollars to put to work, there are still plenty of wonderful companies that you can add to your portfolio, particularly in a time where most broke...

Medical device specialist DexCom (NASDAQ: DXCM) has been on fire over the past year, significantly outperforming the broader market. The healthcare company can thank several tailwinds for its performance, including the continued adoption of the technology it has helped pioneer -- continuo...

DexCom ( NASDAQ: DXCM ) added ~7% on Thursday after the Centers for Medicare and Medicaid Services (CMS) updated its policy on continuous glucose monitors to expand coverage for a broader group of diabetes patients. The change, expected to take effect in April, is a “welcom...